Tissue Changes in Lumbar Multifidus After Dry Needling in Subjects With Nonspecific Low Back Pain.
20 november 2021 uppdaterad av: Sebastián Rodríguez PosadaSebastián Rodríguez Posada, University of Alcala
Association Between Tissue Changes in Lumbar Multifidae and Improvement in Pain and Disability After Dry Needling in Subjects With Nonspecific Low Back Pain. Randomized Clinical Trial.
Finding out if tissue changes (thickness, histogram and shrinkage rate) that occur in the lumbar multifidus after deep dry needling are related to changes in patient's pain and disability.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Lower back pain in regarded as the main cause of disability in the world, which has a significant socio-economic impact. Deep dry needling is effective in handling such pain and is one of the techniques of choice by physiotherapists. In this area, the use of ultrasound provides information of interest such as length, thickness, diameter, cross-sectional area or muscle volume, among others.
Objective: Finding out if tissue changes (thickness, histogram and shrinkage rate) that occur in the lumbar multifidus after deep dry needling are related to changes in patient's pain and disability.
It's a double-blind randomized clinical trial in parallel groups. Patients will be randomly divided into 2 groups. One of them will receive dry needling and the other dry needling placebo. The initial, post-needling and a week after evaluations will be performed by a blinded to the intervention therapist.
Studietyp
Interventionell
Inskrivning (Faktisk)
70
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Madrid
-
Torrejón De Ardoz, Madrid, Spanien, 28850
- Sebastian
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år till 65 år (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- Age between 18 and 65 years.
- Nonspecific pain in the lumbar region.
Exclusion Criteria:
- Previous surgery in the lumbosacral spine.
- Osteoporosis.
- Needle phobia.
- Neurogenic pain with positive tests or negative symptoms.
- Red flags: cauda equina syndrome, sudden weight loss, fracture, cancer, infection or systemic diseases.
- Pregnancy.
- Physiotherapy intervention in the 4 weeks prior to the intervention.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Placebo-jämförare: Control group
Placebo dry needling
|
Placebo dry needling will be performed with DongBang DB100 Acupuncture Needles which, upon contact with the patient, retract, hiding in the needle handle.
The patient will be in the prone position with a pillow in the abdominal region.
The area will be cleaned with an antiseptic and allowed to air dry for 3 minutes.
At the point indicated by the evaluator, the placebo needle will be placed initially and the introduction of the needle and its location will be simulated with the ultrasound system.
10 repetitions will be performed.
The needle will be removed by depositing it in a needle container and a compression will be made in the treated area.
|
|
Experimentell: Experimental group
Dry needling
|
The dry needling will be performed using disposable stainless steel needles (AGU-PUNT needles of size 0.30x50mm or 0.30x60mm depending on the patient) that will be inserted perpendicularly at the point of major hyperalgesia using the Hong technique.
The patient will be in the prone position with a pillow placed in the abdominal region.
The area will be cleaned with an antiseptic and allowed to air dry for 3 minutes.
After this time, the needle will be inserted at the point indicated by the evaluator before reaching the lumbar multifidus by means of echolocation.
Once it is assured that it is in the right place, a total of 10 repetitions are performed.
The needle will be removed by depositing it in a needle container and a compression will be removed in the treated area until hemostasis is achieved.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Changes from baseline in pain on the 10-point Visual Analog Scale (VAS, 0-10 score) at immediatelypost-needling and a week after.
Tidsram: Baseline, immediately post-needling and a week after.
|
This scale shows concurrent and predictive validity in the assessment of pain.
A difference of 2 points represents a clinically significant change that exceeds the limits of measurement error.
|
Baseline, immediately post-needling and a week after.
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Thickness of lumbar multifidus measured with Rehabilitive Ultrasound Imaging in millimeters
Tidsram: Baseline, immediately post-needling and a week after.
|
Baseline, immediately post-needling and a week after.
|
|
|
Histograms using image analysis
Tidsram: Baseline, immediately post-needling and a week after.
|
Baseline, immediately post-needling and a week after.
|
|
|
Pressure Pain threshold
Tidsram: Baseline, immediately post-needling and a week after.
|
It will be measured by using a pressure algometer.
Lumbar multifidus algometry is performed approximately 1.5 cm from the spinous process of the level to be evaluated.
The measurement will be taken 3 times to avoid variability by instructing patients to say verbally when they begin to feel pain.
|
Baseline, immediately post-needling and a week after.
|
|
Disability
Tidsram: Baseline, immediately post-needling and a week after.
|
it will be measured using the Roland-Morris questionnaire.
Values range from 0 (absence of disability) to 24 (maximum level of disability).
|
Baseline, immediately post-needling and a week after.
|
|
Contraction time measured in milliseconds with M-mode
Tidsram: Baseline, immediately post-needling and a week after.
|
The patient performs a hip extension in the prone position
|
Baseline, immediately post-needling and a week after.
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
1 oktober 2021
Primärt slutförande (Faktisk)
8 oktober 2021
Avslutad studie (Faktisk)
8 oktober 2021
Studieregistreringsdatum
Först inskickad
14 september 2021
Först inskickad som uppfyllde QC-kriterierna
23 september 2021
Första postat (Faktisk)
5 oktober 2021
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
23 november 2021
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
20 november 2021
Senast verifierad
1 november 2021
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 210108
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .